A New Way To 'Crowd-Fund' Pharmaceuticals

One of the areas that suffer this “valley of death” dearth of funding is retinitis pigmentosa (RP). RP is a rare, truly genetic disorder that results in the loss of vision for about 200,000 patients annually. One RP patient, a Washington lobbyist, involved in financing has provided a ground-up solution, Bio-Bonds. READ MORE >>